Medical Data Vision Co., Ltd. (TYO:3902)
Japan
· Delayed Price · Currency is JPY 1,680.00
+2.00 (0.12%)
At close: Mar 6, 2026
Medical Data Vision Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 6,539 | 5,906 | 6,419 | 6,104 | 5,672 | Upgrade
|
| Revenue Growth (YoY) | 10.72% | -7.99% | 5.16% | 7.62% | 23.87% | Upgrade
|
| Cost of Revenue | 1,986 | 1,576 | 1,388 | 1,075 | 1,029 | Upgrade
|
| Gross Profit | 4,553 | 4,330 | 5,031 | 5,029 | 4,643 | Upgrade
|
| Selling, General & Admin | 4,203 | 4,025 | 3,162 | 2,938 | 2,732 | Upgrade
|
| Research & Development | - | 290 | 68 | 332 | 316 | Upgrade
|
| Operating Expenses | 4,201 | 4,327 | 3,260 | 3,271 | 3,049 | Upgrade
|
| Operating Income | 352 | 3 | 1,771 | 1,758 | 1,594 | Upgrade
|
| Interest & Investment Income | 3 | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | -5 | -514 | -72 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 10 | 1 | 1 | -8 | -3 | Upgrade
|
| EBT Excluding Unusual Items | 360 | -510 | 1,700 | 1,750 | 1,591 | Upgrade
|
| Gain (Loss) on Sale of Investments | -290 | -127 | -15 | 51 | - | Upgrade
|
| Asset Writedown | -4 | -4 | -116 | -375 | - | Upgrade
|
| Other Unusual Items | - | -86 | -1 | - | -1 | Upgrade
|
| Pretax Income | 66 | -727 | 1,568 | 1,426 | 1,590 | Upgrade
|
| Income Tax Expense | -210 | 76 | 613 | 569 | 491 | Upgrade
|
| Earnings From Continuing Operations | 276 | -803 | 955 | 857 | 1,099 | Upgrade
|
| Minority Interest in Earnings | 4 | 12 | 24 | 13 | -12 | Upgrade
|
| Net Income | 280 | -791 | 979 | 870 | 1,087 | Upgrade
|
| Net Income to Common | 280 | -791 | 979 | 870 | 1,087 | Upgrade
|
| Net Income Growth | - | - | 12.53% | -19.96% | 55.29% | Upgrade
|
| Shares Outstanding (Basic) | 38 | 38 | 38 | 38 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 38 | 38 | 39 | Upgrade
|
| Shares Change (YoY) | -0.79% | -0.10% | -0.10% | -2.44% | -0.81% | Upgrade
|
| EPS (Basic) | 7.40 | -20.73 | 25.63 | 22.75 | 27.74 | Upgrade
|
| EPS (Diluted) | 7.40 | -20.73 | 25.63 | 22.75 | 27.74 | Upgrade
|
| EPS Growth | - | - | 12.64% | -17.97% | 56.55% | Upgrade
|
| Free Cash Flow | 720 | -1,031 | 1,586 | 857 | 1,058 | Upgrade
|
| Free Cash Flow Per Share | 19.02 | -27.02 | 41.52 | 22.41 | 27.00 | Upgrade
|
| Dividend Per Share | - | 6.500 | 6.500 | 6.000 | 5.600 | Upgrade
|
| Dividend Growth | - | - | 8.33% | 7.14% | 55.56% | Upgrade
|
| Gross Margin | 69.63% | 73.31% | 78.38% | 82.39% | 81.86% | Upgrade
|
| Operating Margin | 5.38% | 0.05% | 27.59% | 28.80% | 28.10% | Upgrade
|
| Profit Margin | 4.28% | -13.39% | 15.25% | 14.25% | 19.16% | Upgrade
|
| Free Cash Flow Margin | 11.01% | -17.46% | 24.71% | 14.04% | 18.65% | Upgrade
|
| EBITDA | 460 | 130 | 1,872 | 1,907 | 1,729 | Upgrade
|
| EBITDA Margin | 7.03% | 2.20% | 29.16% | 31.24% | 30.48% | Upgrade
|
| D&A For EBITDA | 108 | 127 | 101 | 149 | 135 | Upgrade
|
| EBIT | 352 | 3 | 1,771 | 1,758 | 1,594 | Upgrade
|
| EBIT Margin | 5.38% | 0.05% | 27.59% | 28.80% | 28.10% | Upgrade
|
| Effective Tax Rate | - | - | 39.09% | 39.90% | 30.88% | Upgrade
|
| Advertising Expenses | - | 508 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.